

A Long-term Safety Extension Study of Mavacamten (MYK-461) in Adults with Hypertrophic Cardiomyopathy Who Have Completed the MAVERICK-HCM (MYK-461-006) or EXPLORER-HCM (MYK-461-005) Trials (MAVA-LTE)
Physician
Dr. Jamshid Shirani
Close
Synopsis: The purpose of this study is to assess the long-term safety and tolerability of mavacamten in participants with non-obstructive hypertrophic cardiomyopathy (nHCM) and obstructive hypertrophic cardiomyopathy (oHCM).
Close
Close
Close
Interested in a
Clinical Trial?